Platelet inhibiting drugs

Antiplatelet agents are drugs that inhibit enzymes or receptors required for platelet activation, platelet aggregation, and/or thrombus

Antiplatelet agents are drugs that inhibit enzymes or receptors required for platelet activation, platelet aggregation, and/or thrombus

Anti-Platelet Drugs . Three groups of drugs are used to reduce the stickiness of platelets, the tiny blood elements that form the nucleus of a blood clot. By inhibiting the ability of platelets to clump together, anti-platelet drugs inhibit blood clotting.

Antiplatelet drugs can reversibly or irreversibly inhibit process involved in platelet activation resulting in decreased tendency of platelet

Mechanism: Possibly via inhibition of serotonin-mediated platelet activation (inhibition of the serotonin reuptake transporter) and subsequent platelet

Antiplatelet drugs are classified on the basis of their site of action, that is, drugs that inhibit (i) platelet adhesion, (ii) platelet activation, (iii) platelet aggregation, and (iv) platelet-mediated links with inflammation . Aspirin belongs to the group of drugs that inhibit platelet activation.

Antiplatelet drugs are primarily directed against platelets and inhibit platelet activation by a number of different mechanisms.

In this video, we explore the major anticoagulant drugs that specifically inhibit platelets (anti-platelet drugs), including their

Antiplatelet drugs are medications that inhibit the aggregation or clumping of platelets in the blood. Abnormal platelet aggregation can